MoneyWorks4Me

Shilpa Medicare informs about annual secretarial compliance report

26 Jun 2021 Evaluate

Pursuant to Regulation 24A of the SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015, read with CIR/CFD/CMD1/27/2019 dated February 8, 2019, Shilpa Medicare has informed that it enclosed the Annual Secretarial Compliance Report of the Company for the financial year 2020-21 issued by P.S. Rao & Associates, Practicing Company Secretaries.

The above information is a part of company’s filings submitted to BSE.

Shilpa Medicare Share Price

813.00 -8.90 (-1.08%)
17-Aug-2026 09:39 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1919.10
Dr. Reddys Labs. 1186.35
Cipla 1440.30
Lupin 2227.85
Zydus Lifesciences 1132.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: